Skip to main content
Erschienen in: International Journal of Legal Medicine 6/2012

01.11.2012 | Case Report

Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin

verfasst von: Benno Hartung, Hans F. Merk, Wolfgang Huckenbeck, Thomas Daldrup, Eva Neuen-Jacob, Stefanie Ritz-Timme

Erschienen in: International Journal of Legal Medicine | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Isotretinoin is considered to be a safe and effective therapy in otherwise therapy-resistant acne. Elevated serum creatine phosphokinase values with or without muscle-related symptoms in isotretinoin-treated patients have been reported and interpreted as benign phenomena, lethal cases have not been described yet. We present the case of a 20-year-old male who died from severe generalised rhabdomyolysis associated with isotretinoin treatment.
Literatur
1.
Zurück zum Zitat Goulden V, Clark SM, McGeown C, Cunliffe WJ (1997) Treatment of acne with intermittent isotretinoin. Br J Dermatol 137:106–108PubMedCrossRef Goulden V, Clark SM, McGeown C, Cunliffe WJ (1997) Treatment of acne with intermittent isotretinoin. Br J Dermatol 137:106–108PubMedCrossRef
2.
Zurück zum Zitat Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS (1983) Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol 9:629–638PubMedCrossRef Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS (1983) Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol 9:629–638PubMedCrossRef
3.
Zurück zum Zitat Layton AM, Knaggs H, Taylor J, Cunliffe WJ (1993) Isotretinoin for acne vulgaris—10 years later: a safe and successful treatment. Br J Dermatol 129:292–296PubMedCrossRef Layton AM, Knaggs H, Taylor J, Cunliffe WJ (1993) Isotretinoin for acne vulgaris—10 years later: a safe and successful treatment. Br J Dermatol 129:292–296PubMedCrossRef
4.
Zurück zum Zitat Bershad S, Rubinstein A, Paterniti JR, Le NA, Poliak SC, Heller B, Ginsberg HN, Fleischmajer R, Brown WV (1985) Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 313:981–985PubMedCrossRef Bershad S, Rubinstein A, Paterniti JR, Le NA, Poliak SC, Heller B, Ginsberg HN, Fleischmajer R, Brown WV (1985) Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 313:981–985PubMedCrossRef
5.
Zurück zum Zitat Dootson GM, Keidan J, Harper PL (1995) The influence of isotretinoin upon fibrinolysis in patients with acne. Br J Dermatol 133:66–70PubMedCrossRef Dootson GM, Keidan J, Harper PL (1995) The influence of isotretinoin upon fibrinolysis in patients with acne. Br J Dermatol 133:66–70PubMedCrossRef
6.
Zurück zum Zitat Rote Liste (2010) Arzneimittelverzeichnis für Deutschland. Rote Liste Service GmbH, Frankfurt Rote Liste (2010) Arzneimittelverzeichnis für Deutschland. Rote Liste Service GmbH, Frankfurt
7.
Zurück zum Zitat Arzneimittelkommission der deutschen Ärzteschaft (2012) Aus der UAW-Datenbank. Isotretinoin und chronisch-entzündliche Darmerkrankung. Dtsch Ärztebl 109:A-1044/ B-900/ C-892 Arzneimittelkommission der deutschen Ärzteschaft (2012) Aus der UAW-Datenbank. Isotretinoin und chronisch-entzündliche Darmerkrankung. Dtsch Ärztebl 109:A-1044/ B-900/ C-892
8.
Zurück zum Zitat McBurney EI, Rosen DA (1984) Elevated creatine phosphokinase with isotretinoin. J Am Acad Dermatol 10:528–529PubMedCrossRef McBurney EI, Rosen DA (1984) Elevated creatine phosphokinase with isotretinoin. J Am Acad Dermatol 10:528–529PubMedCrossRef
9.
Zurück zum Zitat Hodak E, Gadoth N, David M, Sandbank M (1986) Muscle damage induced by isotretinoin. Br Med J 293:425–426CrossRef Hodak E, Gadoth N, David M, Sandbank M (1986) Muscle damage induced by isotretinoin. Br Med J 293:425–426CrossRef
10.
Zurück zum Zitat Guttmann-Yassky E, Hayek T, Muchnik L, Bergman R (2003) Acute rhabdomyolsis and myoglobinuria associated with isotretinoin treatment. Int J Derm 42:499–500CrossRef Guttmann-Yassky E, Hayek T, Muchnik L, Bergman R (2003) Acute rhabdomyolsis and myoglobinuria associated with isotretinoin treatment. Int J Derm 42:499–500CrossRef
11.
Zurück zum Zitat Gomez-Bernal S, Rodriguez-Pazos L, Rodriguez-Granados MT, Toribio J (2011) Rhabdomyolysis during isotretinoin therapy. Actas Dermosifiliogr 102:390–391PubMedCrossRef Gomez-Bernal S, Rodriguez-Pazos L, Rodriguez-Granados MT, Toribio J (2011) Rhabdomyolysis during isotretinoin therapy. Actas Dermosifiliogr 102:390–391PubMedCrossRef
12.
Zurück zum Zitat Trauner MA, Ruben BS (1999) Isotretinoin induced rhabdomyolysis? A case report. Dermatol Online J 5:2PubMed Trauner MA, Ruben BS (1999) Isotretinoin induced rhabdomyolysis? A case report. Dermatol Online J 5:2PubMed
13.
Zurück zum Zitat Heudes AM, Laroche L (1998) Muscular damage during isotretinoin treatment. Ann Dermatol Venereol 125:94–97PubMed Heudes AM, Laroche L (1998) Muscular damage during isotretinoin treatment. Ann Dermatol Venereol 125:94–97PubMed
14.
Zurück zum Zitat Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y (2001) Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin. Acta Derm Venereol 81:350–352PubMedCrossRef Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y (2001) Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin. Acta Derm Venereol 81:350–352PubMedCrossRef
15.
Zurück zum Zitat Kaymak Y (2008) Creatine phosphokinase values during isotretinoin treatment for acne. Int J Derm 47:398–401PubMedCrossRef Kaymak Y (2008) Creatine phosphokinase values during isotretinoin treatment for acne. Int J Derm 47:398–401PubMedCrossRef
16.
Zurück zum Zitat Brinkmann B (1999) Harmonisation of medico-legal autopsy rules. Committee of Ministers. Council of Europe. Int J Leg Med 113:1–14CrossRef Brinkmann B (1999) Harmonisation of medico-legal autopsy rules. Committee of Ministers. Council of Europe. Int J Leg Med 113:1–14CrossRef
17.
Zurück zum Zitat Ferrara SD, Bajanowski T, Cecchi R, Snenghi R, Case C, Viel G (2010) Bio-medical guidelines and protocols: survey and future perspectives in Europe. Int J Leg Med 124:345–350CrossRef Ferrara SD, Bajanowski T, Cecchi R, Snenghi R, Case C, Viel G (2010) Bio-medical guidelines and protocols: survey and future perspectives in Europe. Int J Leg Med 124:345–350CrossRef
18.
Zurück zum Zitat Fracasso T, Karger B, Pfeiffer H, Sauerland C, Schmeling A (2010) Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism. Int J Legal Med 124:537–542PubMedCrossRef Fracasso T, Karger B, Pfeiffer H, Sauerland C, Schmeling A (2010) Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism. Int J Legal Med 124:537–542PubMedCrossRef
19.
Zurück zum Zitat Hartung B, Schott M, Daldrup T, Ritz-Timme S (2010) Lethal thyroid storm after uncontrolled intake of liothyronine in order to lose weight. Int J Legal Med 124:637–640PubMedCrossRef Hartung B, Schott M, Daldrup T, Ritz-Timme S (2010) Lethal thyroid storm after uncontrolled intake of liothyronine in order to lose weight. Int J Legal Med 124:637–640PubMedCrossRef
20.
Zurück zum Zitat Cecchi R, Cipollini L, Sestili C, Aromatario M, Ciallella C (2011) Pulmonary embolisation of bone fragments from penetrating cranial gunshot wounds. Int J Legal Med. doi:10.1007/s00414-011-0643-9 Cecchi R, Cipollini L, Sestili C, Aromatario M, Ciallella C (2011) Pulmonary embolisation of bone fragments from penetrating cranial gunshot wounds. Int J Legal Med. doi:10.​1007/​s00414-011-0643-9
21.
Zurück zum Zitat Fracasso T, Schmeling A (2009) Delayed asphyxia due to inhalation injury. Int J Legal Med 125:289–292CrossRef Fracasso T, Schmeling A (2009) Delayed asphyxia due to inhalation injury. Int J Legal Med 125:289–292CrossRef
22.
Zurück zum Zitat Huerta-Alardin AL, Varon J, Marik PE (2005) Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care 9:158–169PubMedCrossRef Huerta-Alardin AL, Varon J, Marik PE (2005) Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care 9:158–169PubMedCrossRef
24.
Zurück zum Zitat Chroni E, Monastirli A, Tsambaos D (2010) Neuromuscular adverse effects associated with systemic retinoid dermatotherapy. Drug Saf 33:25–34PubMedCrossRef Chroni E, Monastirli A, Tsambaos D (2010) Neuromuscular adverse effects associated with systemic retinoid dermatotherapy. Drug Saf 33:25–34PubMedCrossRef
Metadaten
Titel
Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin
verfasst von
Benno Hartung
Hans F. Merk
Wolfgang Huckenbeck
Thomas Daldrup
Eva Neuen-Jacob
Stefanie Ritz-Timme
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 6/2012
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-012-0750-2

Weitere Artikel der Ausgabe 6/2012

International Journal of Legal Medicine 6/2012 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin